Benefits of mitral valve repair over replacement in the elderly: a systematic review and meta-analysis.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 13 01 2021
accepted: 09 02 2021
pubmed: 31 3 2021
medline: 11 6 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

Mitral valve (MV) repair has demonstrated excellent short- and long-term outcomes, however, its merit in the elderly population is still debated. We conducted a meta-analysis of studies that have compared the MV repair to replacement in the elderly population. A systematic literature search was conducted for any study published on MV surgery on elderly patients (≥75 years old). A pooled risk-ratio meta-analysis was done to evaluate short-term mortality, postoperative complications, surgical timings, and long-term survival rates. A total of nine retrospective observational studies were included in the quantitative meta-analysis. Pooled meta-analysis showed a reduced risk of short-term mortality for the MV repair group (risk ratio [RR] = 0.41 [0.24-0.71], p-value = .005). Postoperative neurological complications were in favor of repair, although not significantly (RR = 0.49 [0.21-1.11], p-value = .07). Operative timings (cardiopulmonary bypass and crossclamp time) were not different between the groups although no data were available on the complexity of the repairs. Long-term survival rates were in favor of the repairs (pooled treatment effect of -0.47 [-0.64; -0.29], p = .005). MV surgery is a safe and effective procedure for the elderly. MV repair demonstrated better short-term outcomes compared to replacement. Long-term survival rates are significantly better after repair.

Identifiants

pubmed: 33783032
doi: 10.1111/jocs.15506
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2524-2530

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.

Références

Ghoreishi M, Dawood MY, Gammie JS. Mitral valve surgery in elderly patients with mitral regurgitation: repair or replacement with tissue valve? Curr Opin Cardiol. 2013;28(2):164-169.
Eurostat. Ageing Europe-statistics on population developments. Available from https://ec.europa.eu/eurostat/statistics-explained/index.php/Population_structure_and_ageing
Pratesi A, Orso F, Ghiara C, et al. Cardiac surgery in the elderly: what goals of care? Monaldi Arch Chest Dis. 2017;87(2):12-15.
Taramasso M, Gaemperli O, Maisano F. Treatment of degenerative mitral regurgitation in elderly patients. Nat Rev Cardiol. 2015;12(3):177-183.
Farid S, Ladwiniec A, Hernández-Sánchez J, et al. Early outcomes after mitral valve repair versus replacement in the elderly: a propensity matched analysis. Hear Lung Circ. 2019;28(2):314-319.
Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg. 2006;82(3):819-826.
Vassileva CM, Mishkel G, McNeely C, et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of medicare fee-for-service beneficiaries. Circulation. 2013;127(18):1870-1876.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:1-16.
Chikwe J, Goldstone AB, Passage J, et al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J. 2011;32(5):618-626.
Silaschi M, Chaubey S, Aldalati O, et al. Is mitral valve repair superior to mitral valve replacement in elderly patients? comparison of short-and long-term outcomes in a propensity-matched cohort. J Am Heart Assoc. 2016;5(8):10-12.
Ailawadi G, Swenson BR, Girotti ME, et al. Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg. 2008;86(1):77-86.
Seese LM, Sultan I, Gleason TG, et al. Outcomes of mitral valve repair versus replacement in the elderly. Ann Thorac Surg. 2020;109(4):1202-1209. https://doi.org/10.1016/j.athoracsur.2019.07.057
Chivasso P, Bruno VD, Farid S, et al. Predictors of survival in octogenarians after mitral valve surgery for degenerative disease: the Mitral Surgery in Octogenarians study. J Thorac Cardiovasc Surg. 2018;155(4):1474-1482. https://doi.org/10.1016/j.jtcvs.2017.11.027
Nloga J, Hénaine R, Vergnat M, et al. Mitral valve surgery in octogenarians: Should we fight for repair? A survival and quality-of-life assessment. Eur J Cardio-thoracic Surg. 2011;39(6):875-880.
DiGregorio V, Zehr KJ, Orszulak TA, et al. Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation. Ann Thorac Surg. 2004;78(3):807-813.
Goldsmith I, Lip GY, Kaukuntla H, Patel RL. Hospital morbidity and mortality and changes in quality of life following mitral valve surgery in the elderly. J Heart Valve Dis. 1999;8:702-707.
Kang DH, Heo R, Lee S, et al. Initial surgery versus conservative management of symptomatic severe mitral regurgitation in the elderly. Heart. 2018;104(10):849-854.
Shang X, Lu R, Liu M, Xiao S, Dong N. Mitral valve repair versus replacement in elderly patients: a systematic review and meta-analysis. J Thorac Dis. 2017;9(9):3045-3051.
Bruno VD, Chivasso P, Hayat A, et al. Propensity-matched analysis of outcomes after mitral valve surgery between trainees and consultants (institutional report). Interact Cardiovasc Thorac Surg. 2018;26(3):443-447.
Medved I, Anić D, Oštrić M, Zrnić B, Ivančić A, Tomulić V. Is mitral valve repair safe procedure in elderly patients? Coll Antropol. 2010;34(SUPPL. 2):213-215.
McNeely C, Vassileva C. Long-term outcomes of mitral valve repair versus replacement for degenerative disease: a systematic review. Curr Cardiol Rev. 2014;11(2):157-162.

Auteurs

Ettorino Di Tommaso (E)

Bristol Medical School, Translational Health Science, University of Bristol, Bristol, UK.

Filippo Rapetto (F)

Bristol Heart Institute, University Hospital Bristol and Weston NHS Foundation Trust, Bristol, UK.

Gustavo A Guida (GA)

Bristol Heart Institute, University Hospital Bristol and Weston NHS Foundation Trust, Bristol, UK.

Mustafa Zakkar (M)

Department of Cardiovascular Sciences, Clinical Sciences Wing, Glenfield General Hospital, University of Leicester, Leicester, UK.

Vito D Bruno (VD)

Bristol Medical School, Translational Health Science, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH